CB
ORCL icon

Chemical Bank’s Oracle ORCL Stock Holding History

Chemical Bank’s Portfolio ORCL Stock Details ORCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$3.52M Sell
61,783
-479
-0.8% -$25.9K 0.4% 66
2019
Q1 		$3.35M Sell
62,262
-482
-0.8% -$24.6K 0.38% 66
2018
Q4 		$2.83M Sell
62,744
-7,910
-11% -$379K 0.35% 68
2018
Q3 		$3.64M Sell
70,654
-1,750
-2% -$85K 0.38% 68
2018
Q2 		$3.19M Sell
72,404
-1,980
-3% -$91.2K 0.34% 71
2018
Q1 		$3.4M Sell
74,384
-3,475
-4% -$173K 0.37% 67
2017
Q4 		$3.68M Sell
77,859
-5,091
-6% -$250K 0.4% 62
2017
Q3 		$4.01M Sell
82,950
-2,173
-3% -$108K 0.44% 56
2017
Q2 		$4.27M Sell
85,123
-5
-0% -$228 0.47% 55
2017
Q1 		$3.8M Sell
85,128
-4,740
-5% -$197K 0.42% 60
2016
Q4 		$3.46M Sell
89,868
-856
-0.9% -$33.5K 0.4% 63
2016
Q3 		$3.56M Buy
90,724
+4,008
+5% +$163K 0.48% 51
2016
Q2 		$3.55M Sell
86,716
-1,960
-2% -$78.3K 0.49% 50
2016
Q1 		$3.63M Sell
88,676
-6,337
-7% -$235K 0.51% 49
2015
Q4 		$3.47M Sell
95,013
-3,430
-3% -$131K 0.48% 52
2015
Q3 		$3.56M Sell
98,443
-1,565
-2% -$60.2K 0.51% 53
2015
Q2 		$4.03M Sell
100,008
-1,125
-1% -$48.8K 0.53% 48
2015
Q1 		$4.36M Sell
101,133
-9,983
-9% -$433K 0.57% 44
2014
Q4 		$5M Buy
111,116
+36,325
+49% +$1.48M 0.65% 37
2014
Q3 		$2.86M Sell
74,791
-1,633
-2% -$66.1K 0.5% 47
2014
Q2 		$3.1M Sell
76,424
-1,934
-2% -$79.6K 0.53% 45
2014
Q1 		$3.21M Sell
78,358
-14,686
-16% -$559K 0.58% 41
2013
Q4 		$3.56M Sell
93,044
-4,465
-5% -$153K 0.63% 36
2013
Q3 		$3.23M Sell
97,509
-29,655
-23% -$962K 0.63% 35
2013
Q2 		$3.9M Buy
+127,164
New +$4.22M 0.77% 30

Other funds holding ORCL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Chemical Bank's ORCL Position: Q2 2019 in Review

Chemical Bank reduced its Oracle (ORCL) stake by 0.77% in Q2 2019, selling an estimated $25.9K and leaving 61,783 shares worth $3.52M. The position accounts for 0.4% of the portfolio, ranked #66.

Chemical Bank first reported a position in ORCL in Q2 2013 and has held it in 25 quarters since. The position peaked at $5M in Q4 2014. 1,816 funds tracked by Wall St. Rank hold ORCL as of Q2 2019.

  • Chemical Bank held 61,783 shares of Oracle worth $3.52M as of Q2 2019.
  • Chemical Bank sold 479 Oracle shares in Q2 2019, an estimated $25.9K.
  • Oracle made up 0.4% of Chemical Bank's portfolio in Q2 2019, its #66 holding.
  • Chemical Bank first reported a position in Oracle in Q2 2013 and has held it in 25 quarters since.
  • Chemical Bank's Oracle position peaked at $5M in Q4 2014.
  • 1,816 funds tracked by Wall St. Rank held Oracle as of Q2 2019.

Based on Chemical Bank's 13F filing for Q2 2019, filed 25 Jul 2019.